We next analyzed how niclosamide affects pathology in the most common mouse model of ALS, SOD1-G93A mice, by administering niclosamide at the dose of 20 ​mg/kg dissolved in 10% Cremophor® (vehicle) or with the vehicle starting at the onset of first symptoms until end-phase. Here, SOD1 is linked to amyotrophic lateral sclerosis.